Back
Alnylam Pharmaceuticals Stock Price Chart
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ALNY
Alnylam Pharmaceuticals
Last Price:
$256.66
Seasonality Move:
-4.38%
7 Day Trial
ALL ACCESS PASS
$
7
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 270.14 | Sell |
| 20-day SMA: | 270.86 | Sell |
| 50-day SMA: | 255.02 | Buy |
| 200-day SMA: | 239.98 | Buy |
| 8-day EMA: | 267.09 | Sell |
| 20-day EMA: | 266.5 | Sell |
| 50-day EMA: | 261.13 | Sell |
| 200-day EMA: | 241.68 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.12 | Buy |
| Relative Strength Index (14 RSI): | 42.86 | Sell |
| Chaikin Money Flow: | -220973 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (253.87 - 278.45) | Sell |
| Bollinger Bands (100): | (245.33 - 280.27) | Sell |
Alnylam Pharmaceuticals Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 256.45 while ALNY 8-day simple moving average is 270.14, which is a Sell signal.
-
The stock price of ALNY is 256.45 while Alnylam Pharmaceuticals 20-day SMA is 270.86, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day simple moving average is 255.02 while ALNY share price is 256.45, making it a Buy technically.
-
ALNY stock price is 256.45 and Alnylam Pharmaceuticals 200-day simple moving average is 239.98, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
37
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a SellThe current Alnylam Pharmaceuticals [ALNY] share price is $256.45. The Score for ALNY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
33.2B
Price in USD:
256.45
Share Volume:
748.1K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
37
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 256.45 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 256.45 while ALNY 8-day exponential moving average is 267.09, which is a Sell signal.
-
The stock price of ALNY is 256.45 while Alnylam Pharmaceuticals 20-day EMA is 266.50, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 261.13 while ALNY share price is 256.45, making it a Sell technically.
-
ALNY stock price is 256.45 and Alnylam Pharmaceuticals 200-day simple moving average is 241.68, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $1.09 per share, a decrease next quarter of $0.14 per share, an increase this year of $1.08 per share, and an increase next year of $2.81 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is 3.12, suggesting Alnylam Pharmaceuticals is a Buy
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 42.86, which suggest Alnylam Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (253.87 - 278.45), which suggest Alnylam Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (245.33 - 280.27), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.